2 completed, 2 unknown. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Unknown 2 |
| Phase 2 | 2 | Unknown 2 |
Follow Hyponatremia: new trials by email Literature Review of Hyponatremia trials Research Report on Hyponatremia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium Cicletanine + magnesium, Cicletanine - Arterial Hypertension, Diabetes | Phase 1 / Phase 2 | Unknown | Navitas Pharma | 24 | 2022-06-01 | 2021-09-05 |
| Safety and Feasibility of Hypertonic Saline Solution After Aneurysmal Subarachnoid Hemorrhage: HTS 3%, Standard fluid management - Subarachnoid Hemorrhage, Cerebral Vasospasm | Phase 1 / Phase 2 | Unknown | Thomas Jefferson University | 50 | 2015-01-01 | 2016-02-11 |
| Study to Compare Conivaptan Pharmacokinetics in Subjects With Mild & Moderate Kidney Function Impairment to Subjects With Normal Kidney Function conivaptan hydrochloride - Kidney Diseases, Hyponatremia | Phase 1 | Completed | Cumberland Pharmaceuticals | 25 | 2009-04-01 | 2014-05-02 |
| Study to Compare Conivaptan in Subjects With Mild & Moderate Liver Impairment Versus Subjects With Normal Liver Function conivaptan hydrochloride - Liver Disease, Hyponatremia | Phase 1 | Completed | Cumberland Pharmaceuticals | 26 | 2009-02-01 | 2014-05-02 |
Diabetes Mellitus (1) · Hypertension (1) · Hypokalemia (1) · Kidney Diseases (1) · Liver Diseases (1) · Metabolic Diseases (1) · Subarachnoid Hemorrhage (1) · Vasospasm, Intracranial (1)
Nutritional and Metabolic Diseases (4) · Water-Electrolyte Imbalance (4) · Metabolic Diseases (3) · Cardiovascular Diseases (2) · Vascular Diseases (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Digestive System Diseases (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Glucose Metabolism Disorders (1) · Hemorrhage (1) · Intracranial Hemorrhages (1)
conivaptan (2) · 5-(3-hydroxybenzoyl)-2-thiophenesulfonamide (1) · Magnesium (1) · cicletanine (1)
Cumberland Pharmaceuticals (2) · Navitas Pharma (1) · Thomas Jefferson University (1)
United States (3)
Art Wheeler, MD (2)